OTCMKTS:BVNRY Bavarian Nordic (BVNRY) Stock Price, News & Analysis $11.79 -0.25 (-2.08%) As of 02:47 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsNews and TrendsShort Interest About Bavarian Nordic Stock (OTCMKTS:BVNRY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Bavarian Nordic alerts:Sign Up Key Stats Today's Range$11.78▼$11.8050-Day Range$10.29▼$12.7252-Week Range$8.67▼$12.72Volume1,205 shsAverage Volume3,311 shsMarket Capitalization$2.80 billionP/E Ratio11.91Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Bavarian Nordic is a Danish biotechnology company that develops, manufactures and markets vaccines for infectious diseases and cancer immunotherapy. Founded in 1994, the company is based in Denmark and serves markets in Europe, North America and other regions. Its best-known vaccine is JYNNEOS, also marketed as IMVANEX in Europe and IMVAMUNE in Canada, for protection against smallpox and mpox. Bavarian Nordic also offers vaccines for diseases including rabies, tick-borne encephalitis, typhoid fever and cholera. The company uses its MVA-BN technology in vaccine development and supplies products to public health authorities as well as commercial markets. Its portfolio includes vaccines developed in-house and products added through acquisitions.AI Generated. May Contain Errors. Read More Receive BVNRY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bavarian Nordic and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BVNRY Stock News HeadlinesBavarian Nordic Awarded 4 Year Mpox And Smallpox Vaccine Supply Contract By UK GovernmentNovember 2, 2026 | rttnews.comBavarian Nordic gets four-year contract for mpox and smallpox vaccine from UK governmentNovember 2, 2026 | reuters.comYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.November 11 at 1:00 AM | Profits Run (Ad)Bavarian Nordic to provide over 200K Mpox shots to global emergency stockpileOctober 27, 2026 | msn.comBavarian Nordic donates 75,000 mpox vaccine doses to global emergency stockpileOctober 27, 2026 | reuters.comBavarian Nordic Earnings Call Signals Profitable GrowthAugust 29, 2026 | tipranks.comBavarian Nordic A/S (BVNRY) Q2 2026 Earnings Call TranscriptAugust 21, 2026 | seekingalpha.comGlobal warming widens spread of TBE, chikungunya, Bavarian Nordic boss saysAugust 21, 2026 | reuters.comSee More Headlines BVNRY Stock Analysis - Frequently Asked Questions How have BVNRY shares performed this year? Bavarian Nordic's stock was trading at $9.9260 at the beginning of 2026. Since then, BVNRY shares have increased by 18.7% and is now trading at $11.78. How were Bavarian Nordic's earnings last quarter? Bavarian Nordic (OTCMKTS:BVNRY) posted its quarterly earnings data on Friday, August, 21st. The company reported $0.46 EPS for the quarter. The company earned $316.47 million during the quarter. Bavarian Nordic had a trailing twelve-month return on equity of 11.97% and a net margin of 24.36%. How do I buy shares of Bavarian Nordic? Shares of BVNRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Bavarian Nordic own? Based on aggregate information from My MarketBeat watchlists, some other companies that Bavarian Nordic investors own include NVIDIA (NVDA), Genmab A/S (GNMSF), Advanced Micro Devices (AMD), Palantir Technologies (PLTR), Siga Technologies (SIGA), Trade Desk (TTD) and Taiwan Semiconductor Manufacturing (TSM). Company Calendar Last Earnings8/21/2026Today11/11/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolOTCMKTS:BVNRY CIKN/A Webwww.bavarian-nordic.com Phone(453) 326-8383Fax45-3326-8380Employees1,692Year Founded1994Profitability EPS (Trailing Twelve Months)$0.99 Trailing P/E Ratio11.91 Forward P/E RatioN/A P/E GrowthN/ANet Income$208.23 million Net Margins24.36% Pretax Margin30.86% Return on Equity11.97% Return on Assets10.55% Debt Debt-to-Equity RatioN/A Current Ratio6.53 Quick Ratio3.91 Sales & Book Value Annual Sales$945.43 million Price / Sales2.97 Cash Flow$1.29 per share Price / Cash Flow9.11 Book Value$8.20 per share Price / Book1.44Miscellaneous Outstanding Shares237,800,000Free FloatN/AMarket Cap$2.80 billion OptionableNot Optionable Beta1.33 Social Links Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (OTCMKTS:BVNRY) was last updated on 11/11/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredTrump’s EO to send this $5 stock ripping higher…?President Trump's December executive order declared space a national security and economic priority, fueling a...Traders Agency | SponsoredThe Withdrawal You'll Never See on Your StatementA proposal circulating in Washington, dubbed the Mar-a-Lago Accord, calls for tariffs and currency pressure to...Bishop Gold Group | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bavarian Nordic Please log in to your account or sign up in order to add this asset to your watchlist. Share Bavarian Nordic With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
